The challenges of colorectal cancer survivorship

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 7, Issue 8, 2009, Pages 883-894

  Denlinger, Crystal S ^a   Barsevick, Andrea M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Colorectal cancer; Late effects; Long term effects; Quality of life; Survivorship

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ANXIETY DISORDER; ARTICLE; BEHAVIOR MODIFICATION; BODY IMAGE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; DEPRESSION; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL SYMPTOM; HEALTH CARE QUALITY; HUMAN; LIFESTYLE MODIFICATION; OVERALL SURVIVAL; PATIENT CARE; PERIPHERAL NEUROPATHY; PROGNOSIS; QUALITY OF LIFE; SENSORY NEUROPATHY; SEXUAL DYSFUNCTION; SLEEP DISORDER; SYMPTOMATOLOGY; URINE INCONTINENCE;

EID: 70349881698     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2009.0058     Document Type: Article

References (110)

1. Rowland JH. What are cancer survivors telling us? Cancer J 2008;14:361-368.
2. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Rim SR, Seeff L, Ahmed F, et al. Colorectal cancer incidence in the United States, 1999-2004. Cancer 2009;115:1967-1976.
4. Edwards BK, Howe HL, Ries LAG, et al. Annual Report to the Nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94:2766-2792.
5. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101:3-27.
6. Moertel C, Fleming T, Macdonald J, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-358. (Pubitemid 20042739)
7. de Gramont A, Boni C, Navarro M, et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years [abstract]. J Clin Oncol 2007;25(Suppl 18S):Abstract 4007.
8. Krook J, Moertel C, Gunderson L, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715.
9. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740. (Pubitemid 39383208)
10. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: The National Academies Press; 2006.
11. Wilson IB, Cleary PD. Linking clinical variable with health-related quality of life. A conceptual model of patients outcomes. JAMA 1995;273:59-65.
12. Baker F, Haffer SC, Denniston M, et al. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer 2003;97:674-681. (Pubitemid 36125845)
13. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer 2005;104(Suppl 11):2565-2576.
14. Lynch BM, Steginga SK, Hawkes AL, et al. Describing and predicting psychological distress after colorectal cancer. Cancer 2008;112:1363-1370.
15. Stein KD, Syrjala KL, Andrykowski MA, et al. Physical and psychological long-term and late effects of cancer. Cancer 2008;112(Suppl 11):2577-2592.
16. de Boer AG, Taskila T, Ojajarvi A, et al. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 2009;301:753-762.
17. Hewitt M, Rowland JH, Yancik R, et al. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58:82-91. (Pubitemid 36110060)
18. Ramsey SD, Berry K, Moinpour C, et al. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 2002;97:1228-1234. (Pubitemid 34478127)
19. Sweeney C, Schmitz KH, Lazovich D, et al. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 2006;98:521-529. (Pubitemid 43898815)
20. Deimling GT, Sterns S, Bowman KF, Kahana B. Functioning and activity participation restrictions among older adult, long-term cancer survivors. Cancer Invest 2007;25:106-116. (Pubitemid 46598170)
21. Given CW, Given B, Azzouz F, et al. Comparison of changes in physical functioning of elderly patients with new diagnoses of cancer. Med Care 2000;38:482-493.
22. Given BA, Given C, Azzouz F, Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res 2001;50:222-232. (Pubitemid 33603812)
23. Deimling GT, Bowman KF, Wagner LJ, et al. The effects of cancer-related pain and fatigue on functioning of older adult, long-term cancer survivors. Cancer Nurs 2007;30:421-433. (Pubitemid 350145154)
24. Kurtz ME, Kurtz JC, Stommel M, et al. Predictors of depressive symptomatology of geriatric patients with colorectal cancer: a longitudinal view. Support Care Cancer 2002;10:494-501. (Pubitemid 36056275)
25. Robb C, Haley WE, Balducci L, et al. Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol Hematol 2007;62:84-91. (Pubitemid 46330795)
26. Hewitt M, Rowland JH, Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol 2002;20:4581-4590. (Pubitemid 35402962)
27. Mullens AB, McCaul KD, Erickson SC, et al. Coping after cancer: risk perceptions, worry, and health behaviors among colorectal cancer survivors. Psychooncology 2004;13:367-376.
28. Deimling GT, Stems S, Bowman KF, Kahana B. The health of older-adult, long-term cancer survivors. Cancer Nurs 2005;28:415-424. (Pubitemid 44378095)
29. Deimling GT, Wagner LJ, Bowman KF, et al. Coping among older-adult, long-term cancer survivors. Psychooncology 2006;15:143-159.
30. Stommel M, Kurtz ME, Kurtz JC, et al. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol 2004;23:564-573. (Pubitemid 39447326)
31. Ramsey SD, Andersen MR, Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer 2000;88:1294-1303. (Pubitemid 30155164)
32. Schneider EC, Malin JL, Kahn KL, et al. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 2007;110:2075-2082. (Pubitemid 350036869)
33. Trentham-Dietz A, Remington PL, Moinpour CM, et al. Health-related quality of life in female long-term colorectal cancer survivors. Oncologist 2003;8:342-349. (Pubitemid 36929719)
34. Sapp AL, Trentham-Dietz A, Newcomb PA, et al. Social networks and quality of life among female long-term colorectal cancer survivors. Cancer 2003;98:1749-1758. (Pubitemid 37238633)
35. Holland JC, Andersen B, Breitbart WS, et al. NCCN Clinical Practice Guidelines in Oncology: Distress Management. Version 2, 2009. Available at: http://www.nccn.org/professionals/physician-gls/PDF/distress.pdf. Accessed July 16, 2009.
36. Allai AS, Gervaz P, Gertsch P, et al. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 2005;61:1129-1135. (Pubitemid 40340907)
37. Sideris L, Zenasni F, Vernerey D, et al. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients' characteristics. Dis Colon Rectum 2005;48:2180-2191. (Pubitemid 43074437)
38. Guren MG, Eriksen MT, Wiig JN, et al. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 2005;31:735-742. (Pubitemid 41194650)
39. Arndt V, Merx H, Stegmaier C, et al. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 2004;22:4829-4836. (Pubitemid 41185096)
40. Rauch P, Miny J, Conroy T, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004;22:354-360. (Pubitemid 41095100)
41. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - a Dutch Colorectal Cancer Group Study. J Clin Oncol 2005;23:6199-6206.
42. Cersosimo RJ. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 2005;39:128-135.
43. Grothey A. Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 2003;30:5-13.
44. Kaley TJ, DeAngelis LM. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol 2009;145:3-14.
45. Cavaletti G, Petruccioli MG, Marmiroli P, et al. Circulating nerve growth factor levels changes during oxaliplatin treatment-induced neurotoxicity in the rat. Anticancer Res 2002;22:4199-4204. (Pubitemid 36134457)
46. Gamelin L, Capitain O, Morel A, et al. Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway. Clin Cancer Res 2007;13:6359-6368. (Pubitemid 350075025)
47. Grolleau F, Gamelin L, Boisdron-Celle M, et al. A Possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001;85:2293-2297. (Pubitemid 32440704)
48. Park SB, Goldstein D, Lin CS, et al. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 2009;27:1243-1249.
49. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-2351. (Pubitemid 38702845)
50. Kuebler JP, Wieand S, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198-2204. (Pubitemid 46954643)
51. Land SR, Kopec JA, Cecchini RS, et al. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II, and III colon cancer: NSABP C-07. J Clin Oncol 2007;25:2205-2211. (Pubitemid 46954644)
52. Yothers G, Land SR, Ganz PA, et al. Neurotoxicity (NT) in colon cancer (CC) survivors from NSABP protocol C-07 comparing 5-FU + leucovorin (FULV) with the same regimen + oxaliplatin (FLOX): preliminary results from NSABP protocol LTS-0, [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 9575.
53. Wang WS, Lin JK, Lin TC, et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 2007;12:312-319.
54. Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2002;20:3478-3483. (Pubitemid 34894681)
55. Gedlicka C, Scheithauer W, Schull B, Kornek GV. Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. J Clin Oncol 2002;20:3359-3361. (Pubitemid 34831539)
56. Argyriou AA, Chroni E, Polychronopoulos P, et al. Efficacy of oxcarbazepine for porphylaxis against cumulative oxaliplatin-induced neuropathy. Neurology 2006;67:2253-2255. (Pubitemid 46035491)
57. Mitchell P, Goldstein D, Michael M, et al. Addition of gabapentin to a modified folfox regimen does not reduce oxaliplatin-induced neurotoxicity. Clin Colorectal Cancer 2006;6:146-151. (Pubitemid 44445750)
58. von Delius S, Eckel F, Wagenpfeil S, et al. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Invest New Drugs 2007;25:173-180. (Pubitemid 46020877)
59. Gamelin L, Boisdron-Celle M, Delva R, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res 2004;10:4055-4061. (Pubitemid 38812481)
60. Hochster HS, Grothey A, Shpilsky A, Childs BH. Effect of intravenous (IV) calcium and magnesium (Ca/Mg) versus placebo on response to FOLFOX+bevacizumab (BEV) in the CONcePT trial. Presented at the ASCO 2008 Gastrointestinal Cancers Symposium; Orlando, Florida; January 25-27, 2008.
61. Nikcevich DA, Grothey A, Sloan JA, et al. Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: results of the phase III placebo-controlled, double-blind NCCTG trial N04C7 [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 4009.
62. Hochster HS, Grothey A, Childs BH. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 2007;25:4028-4029. (Pubitemid 47477294)
63. Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2003;18:987-994. (Pubitemid 37475958)
64. DeSnoo L, Faithfull S. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. Eur J Cancer Care (Engl) 2006;15:244-251. (Pubitemid 44050695)
65. Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008;95:206-213.
66. Dahlberg M, Glimelius B, Graf W, Påhlman L. Preoperative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum 1998;41:543-549.
67. Hassan I, Larson D, Cima R, et al. Long-term functional and quality of life outcomes after coloanal anastomosis for distal rectal cancer. Dis Colon Rectum 2006;49:1266-1274. (Pubitemid 44401374)
68. Kollmorgen CF, Meagher AP, Wolff BG, et al. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676-682.
69. Lundby L, Krogh K, Jensen VJ, et al. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum 2005;48:1343-1352. (Pubitemid 40933861)
70. McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 2004;90:2278-2287. (Pubitemid 38961889)
71. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 2005;54:1051-1054.
72. Baxter NN, Habermann EB, Tepper JE, et al. Risk of pelvic fractures in older women following pelvic irradiation. JAMA 2005;294:2587-2593.
73. Small W Jr, Kachnic L. Postradiotherapy pelvic fractures: cause for concern or opportunity for future research? JAMA 2005;294:2635-2637.
74. Lange MM, Maas CP, Marijnen CA, et al. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 2008;95:1020-1028.
75. Lange MM, Marijnen CA, Maas CP, et al. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009;45:1578-1588.
76. Pollack J, Holm T, Cedermark B, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 2006;93:1519-1525. (Pubitemid 44893654)
77. Mannaerts GH, Schijven MP, Hendrikx A, et al. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol 2001;27:265-272. (Pubitemid 32621751)
78. Havenga K, Enker WE, McDermott K, et al. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996;182:495-502. (Pubitemid 26176481)
79. Wolf JK. Prevention and treatment of vaginal stenosis resulting from pelvic radiation therapy. Community Oncology 2006;3:665-671.
80. Lindsey I, George B, Kettlewell M, Mortensen N. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease. Dis Colon Rectum 2002;45:727-732. (Pubitemid 34602484)
81. Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 1999;11:46-48. (Pubitemid 29154632)
82. Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003;53:268-291. (Pubitemid 37270571)
83. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814-5830. (Pubitemid 46300178)
84. Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol 2008;26:2198-2204.
85. Jones LW, Courneya KS, Fairey AS. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 2004;28:105-113.
86. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006;24:3535-3541. (Pubitemid 46630523)
87. Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:3527-3534. (Pubitemid 46630522)
88. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638. (Pubitemid 36459468)
89. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003;98:484-495.
90. Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006;98:1647-1654. (Pubitemid 44811647)
91. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 2008;26:4109-4115.
92. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 2004;22:648-657. (Pubitemid 41095068)
93. Moon H, Ju Y, Jeong C, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008;15:1918-1922.
94. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007;298:754-764. (Pubitemid 47263158)
95. Fuchs C, Meyerhardt JA, Heseltine DL, et al. Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from Intergroup trial CALGB 89803 [abstract]. J Clin Oncol 2005;23(Suppl 1):Abstract 3530.
96. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26:2984-2991.
97. Jackson NA, Fuchs CS, Niedzwiecki D, et al. The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: findings from Intergroup trial CALGB 89803 [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 4039.
98. Sargent DJ, Patiyil S, Yothers G, et al. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT group. J Clin Oncol 2007;25:4569-4574. (Pubitemid 350035314)
99. Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872-877.
100. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101:1712-1719. (Pubitemid 39314734)
101. Snyder CF, Earle CC, Herbert RJ, et al. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol 2008;26:1073-1079.
102. Haggstrom D, Arora N, Oakley-Girvan I. Primary and subspecialty care models of follow-up care delivery among colorectal cancer survivors [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 6540.
103. Snyder C, Earle C, Herbert R, et al. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med 2008;23:254-259.
104. Nissen MJ, Beran MS, Lee MW, et al. Views of primary care physicians on follow-up care of cancer patients. Fam Med 2007;39:477-482. (Pubitemid 47052517)
105. Sabatino SA, Coates RJ, Uhler RJ, et al. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol 2007;25:2100-2106. (Pubitemid 46972797)
106. Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol 2006;24:5117-5124.
107. Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol 2006;24:5112-5116.
108. Berger AM, Abernethy AP, Atkinson A, et al. NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1, 2009. Available at: http://www.nccn.org/professionals/physician-gls/PDF/fatigue.pdf. Accessed July 16, 2009.
109. Mitchell SA, Beck SL, Hood LE, et al. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 2007;11:99-113.
110. Page MS, Berger AM, Johnson LB. Putting evidence into practice: evidence-based interventions for sleep-wake disturbances. Clin J Oncol Nurs 2006;10:753-767.